Merit Financial Group, LLC Annovis Bio, Inc. Transaction History
Merit Financial Group, LLC
- $4.59 Billion
- Q3 2024
A detailed history of Merit Financial Group, LLC transactions in Annovis Bio, Inc. stock. As of the latest transaction made, Merit Financial Group, LLC holds 26,700 shares of ANVS stock, worth $133,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,700
Previous 21,700
23.04%
Holding current value
$133,500
Previous $124,000
73.39%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ANVS
# of Institutions
46Shares Held
1.17MCall Options Held
229KPut Options Held
934K-
Vanguard Group Inc Valley Forge, PA380KShares$1.9 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il103KShares$513,4600.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$503,5450.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.1KShares$495,5700.0% of portfolio
-
Group One Trading, L.P. Chicago, IL52.8KShares$263,8350.02% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $40.8M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...